All In Biotech

Drug Trial Radar · NCT01018992

Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder

Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder

Last checked: Nov 19, 2026Latest source record: Mar 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 267 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

267

Actual

Start

Dec 2009

Primary completion

Aug 2014

Study completion Aug 2014

Sponsor

Lead sponsor
Emory UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Icahn School of Medicine at Mount Sinai
First posted
Nov 25, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Diagnostic
Who can join
Female only, from 21 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will test the hypothesis of whether an antagonist at the corticotropin releasing factor type 1 (CRF1) receptor (i.e. GSK561679) is superior to placebo in reducing symptoms of post-traumatic stress disorder (PTSD).

Conditions

  • Stress Disorders, Post-Traumatic

Interventions

  • GSK561679Drug

    GSK561679, oral administration, 350mg/day, 6 week administration

  • PlaceboDrug

    Matching placebo, oral administration, 1 pill/day for 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy, Measured by Change in the Clinician-Administered PTSD Scale (CAPS) ScoreTime frame: Baseline, Week 6

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Stress and Health Research Program, San Francisco VA Medical Center, University of California San Francisco

    San Francisco, California

  • Emory University

    Atlanta, Georgia

  • Mount Sinai School of Medicine

    New York, New York

  • Baylor College of Medicine

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.